Bronchiectasis Alternative Treatment

Cellular Therapy – An Alternative Treatment for Bronchiectasis

For those who are coping with the effects of bronchiectasis, the Lung Institute offers a promising alternative to traditional treatment: cellular therapy. Unlike antibiotic medications, mucus-thinning devices and supplemental oxygen, this groundbreaking option capitalizes on the power of a patient’s own cells, which can promote healing, improve lung function and ultimately enhance quality of life.

Through extensive research, the scientists and clinicians at the Lung institute have discovered that cells have the remarkable capacity to trigger the repair of damaged lung tissue. For this reason, cellular therapy may be a good alternative for addressing the lung scarring that results from bronchiectasis and other chronic obstructive lung conditions.

The Lung Institute offers two main types of alternative treatment for bronchiectasis. Both stem cell procedures are minimally invasive and performed on an outpatient basis in our comfortable facility. We begin by taking a sample of a patient’s blood or bone marrow. Immediately afterward, we process the sample in our onsite lab to isolate the cells. After being reintroduced to the patient’s body intravenously, the highly concentrated cells can travel through the bloodstream to reach the lungs and jumpstart the healing process. Throughout the course of this natural treatment, the patient is overseen by our knowledgeable and compassionate staff.

The science of regenerative medicine continues to show extraordinary promise. Of course, in the practice of any type of medicine, standardized treatments are administered to unique individuals. Therefore, the results of cellular therapy – and any other treatment – can vary. With that said, improvement is a constant process at the Lung Institute. We are continually developing and evaluating novel therapeutic approaches that can potentially help many people who are living with the damaging effects of long-term respiratory conditions. Many patients who receive cellular therapy at the Lung Institute report experiencing a gradual improvement in their symptoms over time.

If you’ve been diagnosed with bronchiectasis, cellular therapy may be an alternative for you. Contact us at (800) 729-3065 to discuss your options.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.